Clinical Trial Update: Platelet-derived Factors for Treatment of Muscular Lesions [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating platelet-derived factors for treating muscle lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Lesions

Drugs mentioned

• Platelet-derived factors (platelet-derived factors)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Muscle Lesions | Phase 2 | Status: COMPLETED